Cargando…

Gut Dysbiosis and Hemodynamic Changes as Links of the Pathogenesis of Complications of Cirrhosis

The aim was to evaluate the relationship between gut dysbiosis and hemodynamic changes (hyperdynamic circulation) in cirrhosis, and between hemodynamic changes and complications of this disease. This study included 47 patients with cirrhosis. Stool microbiome was assessed using 16S rRNA gene sequenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Efremova, Irina, Maslennikov, Roman, Poluektova, Elena, Zharkova, Maria, Kudryavtseva, Anna, Krasnov, George, Fedorova, Maria, Shirokova, Elena, Kozlov, Evgenii, Levshina, Anna, Ivashkin, Vladimir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537778/ https://www.ncbi.nlm.nih.gov/pubmed/37764046 http://dx.doi.org/10.3390/microorganisms11092202

Ejemplares similares

Effect of probiotics on hemodynamic changes and complications associated with cirrhosis: A pilot randomized controlled trial
por: Maslennikov, Roman, et al.
Publicado: (2022)

Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2022)

Gut dysbiosis and body composition in cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2022)

Gut-liver axis in cirrhosis: Are hemodynamic changes a missing link?
por: Maslennikov, Roman, et al.
Publicado: (2021)

Gut dysbiosis is associated with poorer long-term prognosis in cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2021)

Probiotic Saccharomyces boulardii in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2022)

Probiotics in hepatology: An update
por: Maslennikov, Roman, et al.
Publicado: (2021)

Epidemiology of small intestinal bacterial overgrowth
por: Efremova, Irina, et al.
Publicado: (2023)

Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota
por: Maslennikov, Roman, et al.
Publicado: (2023)

Small Intestinal Bacterial Overgrowth Is Associated with Poor Prognosis in Cirrhosis
por: Efremova, Irina, et al.
Publicado: (2023)

Immune disorders and rheumatologic manifestations of viral hepatitis
por: Maslennikov, Roman, et al.
Publicado: (2021)

Differences in Fecal Short-Chain Fatty Acids between Alcoholic Fatty Liver-Induced Cirrhosis and Non-alcoholic (Metabolic-Associated) Fatty Liver-Induced Cirrhosis
por: Cao, Xinlu, et al.
Publicado: (2023)

Impact of vaccination against the novel coronavirus infection (COVID-19) with Sputnik V on mortality during the delta variant surge
por: Dmitrieva, Ksenia, et al.
Publicado: (2023)

Eubiotic effect of rifaximin is associated with decreasing abdominal pain in symptomatic uncomplicated diverticular disease: results from an observational cohort study
por: Ivashkin, Vladimir, et al.
Publicado: (2023)

Effect of Rebamipide on the Intestinal Barrier, Gut Microbiota Structure and Function, and Symptom Severity Associated with Irritable Bowel Syndrome and Functional Dyspepsia Overlap: A Randomized Controlled Trial
por: Kovaleva, Aleksandra, et al.
Publicado: (2023)

Early viral versus late antibiotic-associated diarrhea in novel coronavirus infection
por: Maslennikov, Roman, et al.
Publicado: (2021)

Clostridioides difficile co-infection in patients with COVID-19
por: Maslennikov, Roman, et al.
Publicado: (2022)

Efficacy and safety of COVID-19 vaccination in patients with cirrhosis
por: Ivashkin, Vladimir, et al.
Publicado: (2022)

Gut Microbiota and Bacterial Translocation in the Pathogenesis of Liver Fibrosis
por: Maslennikov, Roman, et al.
Publicado: (2023)

Interleukin 17 antagonist netakimab is effective and safe in the new coronavirus infection (COVID-19)
por: Maslennikov, Roman, et al.
Publicado: (2021)

Tofacitinib reduces mortality in coronavirus disease 2019 Tofacitinib in COVID-19
por: Maslennikov, Roman, et al.
Publicado: (2021)

NT-proBNP as a biomarker for hyperdynamic circulation in decompensated cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2018)

Comprehensive Genetic Study of Malignant Cervical Paraganglioma
por: Snezhkina, Anastasiya, et al.
Publicado: (2023)

Dos ataques de diarrea consecutivos en 15 pacientes de COVID-19: uno asociado con antibióticos posterior a uno viral
por: Maslennikov, R., et al.
Publicado: (2022)

Two consecutive attacks of diarrhea in 15 COVID-19 patients: An antibiotic-associated one following the viral one()
por: Maslennikov, R., et al.
Publicado: (2022)

Somatic Mutation Profiling in Head and Neck Paragangliomas
por: Savvateeva, Maria, et al.
Publicado: (2022)

Oral Dysbiosis in Pancreatic Cancer and Liver Cirrhosis: A Review of the Literature
por: Mohammed, Hiba, et al.
Publicado: (2018)

Efficacy of a Probiotic Consisting of Lacticaseibacillus rhamnosus PDV 1705, Bifidobacterium bifidum PDV 0903, Bifidobacterium longum subsp. infantis PDV 1911, and Bifidobacterium longum subsp. longum PDV 2301 in the Treatment of Hospitalized Patients with COVID-19: a Randomized Controlled Trial
por: Ivashkin, Vladimir, et al.
Publicado: (2021)

Efficacy and safety of a food supplement with standardized menthol, limonene, and gingerol content in patients with irritable bowel syndrome: A double-blind, randomized, placebo-controlled trial
por: Ivashkin, Vladimir T., et al.
Publicado: (2022)

Docetaxel Resistance in Castration-Resistant Prostate Cancer: Transcriptomic Determinants and the Effect of Inhibiting Wnt/β-Catenin Signaling by XAV939
por: Pudova, Elena, et al.
Publicado: (2022)

A Recent Ten-Year Perspective: Bile Acid Metabolism and Signaling
por: Shulpekova, Yulia, et al.
Publicado: (2022)

Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis
por: Nishikawa, Hiroki, et al.
Publicado: (2020)

Differentially methylated CpG sites associated with the high-risk group of prostate cancer
por: Kobelyatskaya, Anastasiya, et al.
Publicado: (2020)

Effects of Abies sibirica terpenes on cancer- and aging-associated pathways in human cells
por: Kudryavtseva, Anna, et al.
Publicado: (2016)

Transcriptome Profiling of Prostate Cancer, Considering Risk Groups and the TMPRSS2-ERG Molecular Subtype
por: Kobelyatskaya, Anastasiya A., et al.
Publicado: (2023)

The SDHD:p.H102R Variant Is Frequent in Russian Patients with Head and Neck Paragangliomas and Associated with Loss of 11p15.5 Region and Hypermethylation of H19-DMR
por: Snezhkina, Anastasiya, et al.
Publicado: (2022)

Disruption of the pro-inflammatory, anti-inflammatory cytokines and tight junction proteins expression, associated with changes of the composition of the gut microbiota in patients with irritable bowel syndrome
por: Ivashkin, V., et al.
Publicado: (2021)

Environment, dysbiosis, immunity and sex-specific susceptibility: A translational hypothesis for regressive autism pathogenesis
por: Mezzelani, Alessandra, et al.
Publicado: (2015)

Hemodynamic alterations in cirrhosis and portal hypertension
por: Kim, Moon Young, et al.
Publicado: (2010)

The Pathogenesis of Hepatic Cirrhosis
por: Johnson, A. S.
Publicado: (1943)

Cannot write session to /tmp/vufind_sessions/sess_ip1t7aqpo00hqm7t7nq8ldm6st